]>
IRCT20170121032085N1 IRCT 2017-12-03 Vice chancellor for research, shahid beheshty University of Medical Sciences The effect of local magnesium sulfate on the progression of effacement, dilatation, process and delivery outcomes The effect of local magnesium sulfate on the progression of effacement, dilatation, process and delivery outcomes in nulipar women 2017-02-26 anticipated 72 Complete https://irct.ir/trial/25084 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Other, Other design features: There is no other explanation, Randomization description: Randomization was done using random numbers tabel . For the control and intervention group, codes A and B were used as contractions. Then, before the intervention, using Excel software, a randomized table for the order of sampling was prepared, Blinding description: Before starting the intervention, all the specimens needed explanations, but the samples were not known to be in the intervention or control group. The drug or placebo was prescribed by the investigator, but the assistant in the study who performed the examinations with him from the treatment group was unaware. The attending physician was aware of the patient's treatment group, but the person analyzing the statistical information from the treatment group was unaware. 3 labor progress. Intervention 1: In the intervention group in the active phase of labor, 10 cc magnesium sulfate is shed 50% on the uterine cavity. If within 2 hours after examination of the uterine cavity, the other 10 cc magnesium sulfate 50% on the uterine crater Shed. Intervention 2: In the control group, in the active phase of labor, 10 cc of water is excreted in the uterine cavity. If, during the next 2 hours, the condition of the uterine cavity has not changed in the examination, once again 10 cc of mucosal sulfate is poured over t. No - There is not a plan to make this available Justification or reason for not sharing IPD is To keep confidential secrets of contributors
public Arezoo Heydari
Tehran, Valiasr Ave., opposite Shahid Rajaee Hospital, Faculty of Nursing Midwifery
Tehran Iran (Islamic Republic of) 1985717443 +98 21 8865 5366 Arezuheydari71@gmail.com Shahid Beheshti university of medcal science scientific Arezu Heydari
Tehran, Valiasr Ave., opposite Shahid Rajaee Hospital, Faculty of Nursing Midwifery
Tehran Iran (Islamic Republic of) 1985717443 +98 21 8865 5366 Arezuheydari71@gmail.com Shahid Beheshti university of Medical science Iran (Islamic Republic of) All nulipar pregnant women Gestational age 37-42 weeks 18-35 years old Live and single fetus cefalic presentasion 18 years 35 years Female Having chronic, risky illness CPD disorder Estimated baby weight more than 4000 grams or less than 2500 grams High risk pregnancy Having history of infertility - - Treatment - Drugs Treatment - Drugs In the intervention group in the active phase of labor, 10 cc magnesium sulfate is shed 50% on the uterine cavity. If within 2 hours after examination of the uterine cavity, the other 10 cc magnesium sulfate 50% on the uterine crater Shed In the control group, in the active phase of labor, 10 cc of water is excreted in the uterine cavity. If, during the next 2 hours, the condition of the uterine cavity has not changed in the examination, once again 10 cc of mucosal sulfate is poured over t During the active phase of labor. Timepoint: During the intervention. Method of measurement: Vaginal examination. Type of delivery. Timepoint: at the birth. Method of measurement: questionnaire. Apgar scores in minutes 1 and 5. Timepoint: 1 and 5 minute after delivery. Method of measurement: observe. Postpartum haemorrhage and laceration of the delivery channel. Timepoint: After delivery and intervention. Method of measurement: Blood testing and inspection. Vice chancellor for research, shahid beheshty University of Medical Sciences Approved 2016-07-18 Shahid Beheshti university of Medical science Tehran, Valiasr St., in front of Shahid Rajaee Heart Hospital, Faculty of Nursing and Midwifery Tehran Tehran Iran (Islamic Republic of)